PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas (vol 113, pg 1020, 2015)

被引:9
作者
Black, Jonathan D.
Lopez, Salvatore
Cocco, Emiliano
Bellone, Stefania
Altwerger, Gary
Schwab, Carlton L.
English, Diana P.
Bonazzoli, Elena
Predolini, Federica
Ferrari, Francesca
Ratner, Elena
Silasi, Dan-Arin
Azodi, Masoud
Schwartz, Peter E.
Santin, Alessandro D.
机构
关键词
D O I
10.1038/bjc.2015.388
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Correction to: British Journal of Cancer (2015) 113, 1020–1026. doi:10.1038/bjc.2015.306 It has been brought to our attention that there is an error in Figure 3 of the above paper published in advance online on 1 September 2015. The original label above the figure reads as ‘ARK-2 E93Q’. It should becorrected to ‘ARK-2 R93Q’.
引用
收藏
页码:1641 / 1641
页数:1
相关论文
共 1 条
  • [1] PIK3CA oncogenic mutations represent a major mechanism of resistance to trastuzumab in HER2/neu overexpressing uterine serous carcinomas
    Black, Jonathan D.
    Lopez, Salvatore
    Cocco, Emiliano
    Bellone, Stefania
    Altwerger, Gary
    Schwab, Carlton L.
    English, Diana P.
    Bonazzoli, Elena
    Predolini, Federica
    Ferrari, Francesca
    Ratner, Elena
    Silasi, Dan-Arin
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    [J]. BRITISH JOURNAL OF CANCER, 2015, 113 (07) : 1020 - 1026